Literature DB >> 19457100

Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia.

Gregg D Stanwood1, Duncan B Leitch, Valentina Savchenko, Jane Wu, Vanessa A Fitsanakis, Douglas J Anderson, Jeannette N Stankowski, Michael Aschner, BethAnn McLaughlin.   

Abstract

Manganese is an essential nutrient, integral to proper metabolism of amino acids, proteins and lipids. Excessive environmental exposure to manganese can produce extrapyramidal symptoms similar to those observed in Parkinson's disease (PD). We used in vivo and in vitro models to examine cellular and circuitry alterations induced by manganese exposure. Primary mesencephalic cultures were treated with 10-800 microM manganese chloride which resulted in dramatic changes in the neuronal cytoskeleton even at subtoxic concentrations. Using cultures from mice with red fluorescent protein driven by the tyrosine hydroxylase (TH) promoter, we found that dopaminergic neurons were more susceptible to manganese toxicity. To understand the vulnerability of dopaminergic cells to chronic manganese exposure, mice were given i.p. injections of MnCl(2) for 30 days. We observed a 20% reduction in TH-positive neurons in the substantia nigra pars compacta (SNpc) following manganese treatment. Quantification of Nissl bodies revealed a widespread reduction in SNpc cell numbers. Other areas of the basal ganglia were also altered by manganese as evidenced by the loss of glutamic acid decarboxylase 67 in the striatum. These studies suggest that acute manganese exposure induces cytoskeletal dysfunction prior to degeneration and that chronic manganese exposure results in neurochemical dysfunction with overlapping features to PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457100      PMCID: PMC2737271          DOI: 10.1111/j.1471-4159.2009.06145.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  84 in total

1.  On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level.

Authors:  Y Takagi; A Okada; K Sando; M Wasa; H Yoshida; N Hirabuki
Journal:  JPEN J Parenter Enteral Nutr       Date:  2001 Mar-Apr       Impact factor: 4.016

Review 2.  Functional aspects of cellular microcompartmentation in the development of neurodegeneration: mutation induced aberrant protein-protein associations.

Authors:  Judit Ovádi; Ferenc Orosz; Susan Hollán
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 3.  Brain development and susceptibility to damage; ion levels and movements.

Authors:  Maria Erecinska; Shobha Cherian; Ian A Silver
Journal:  Curr Top Dev Biol       Date:  2005       Impact factor: 4.897

4.  Determining the oxidation states of manganese in PC12 and nerve growth factor-induced PC12 cells.

Authors:  Karlene K Gunter; Michael Aschner; Lisa M Miller; Roman Eliseev; Jason Salter; Katie Anderson; Sean Hammond; Thomas E Gunter
Journal:  Free Radic Biol Med       Date:  2005-03-31       Impact factor: 7.376

5.  Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways.

Authors:  Julie A Moreno; Kelly A Sullivan; David L Carbone; William H Hanneman; Ronald B Tjalkens
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

6.  Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese.

Authors:  J J Liccione; M D Maines
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

7.  Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism.

Authors:  Abigail M Brown; Ariel Y Deutch; Roger J Colbran
Journal:  Eur J Neurosci       Date:  2005-07       Impact factor: 3.386

Review 8.  Manganese neurotoxicity.

Authors:  Allison W Dobson; Keith M Erikson; Michael Aschner
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 9.  Manganism and idiopathic parkinsonism: similarities and differences.

Authors:  D B Calne; N S Chu; C C Huang; C S Lu; W Olanow
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

10.  Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.

Authors:  G D Zeevalk; E Derr-Yellin; W J Nicklas
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

View more
  48 in total

1.  Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.

Authors:  Peijian Yue; Lin Gao; Xuejing Wang; Xuebing Ding; Junfang Teng
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

2.  Manganese alters rat brain amino acids levels.

Authors:  Dinamene Santos; M Camila Batoreu; Isabel Almeida; Ruben Ramos; M Sidoryk-Wegrzynowicz; Michael Aschner; A P Marreilha dos Santos
Journal:  Biol Trace Elem Res       Date:  2012-09-13       Impact factor: 3.738

3.  Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity.

Authors:  Jerome A Roth; Michelle Eichhorn
Journal:  Neurotoxicology       Date:  2013-04-27       Impact factor: 4.294

4.  SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity.

Authors:  Dinorah Leyva-Illades; Pan Chen; Charles E Zogzas; Steven Hutchens; Jonathan M Mercado; Caleb D Swaim; Richard A Morrisett; Aaron B Bowman; Michael Aschner; Somshuvra Mukhopadhyay
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

5.  The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity.

Authors:  Edward Pajarillo; Asha Rizor; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  J Biol Chem       Date:  2020-01-30       Impact factor: 5.157

6.  Dysregulation of TFEB contributes to manganese-induced autophagic failure and mitochondrial dysfunction in astrocytes.

Authors:  Ziyan Zhang; Jingqi Yan; Aaron B Bowman; Miles R Bryan; Rajat Singh; Michael Aschner
Journal:  Autophagy       Date:  2019-11-24       Impact factor: 16.016

7.  Toxic effects of nicotinamide methylation on mouse brain striatum neuronal cells and its relation to manganese.

Authors:  Yayoi Mori; Akiko Sugawara; Masayoshi Tsuji; Takeyasu Kakamu; Satoshi Tsuboi; Hideyuki Kanda; Takehito Hayakawa; Tetsuhito Fukushima
Journal:  Environ Health Prev Med       Date:  2012-01-15       Impact factor: 3.674

8.  Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.

Authors:  Zhaobao Yin; Haiyan Jiang; Eun-Sook Y Lee; Mingwei Ni; Keith M Erikson; Dejan Milatovic; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2009-12-09       Impact factor: 5.372

9.  Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats.

Authors:  Sanders A McDougall; Alena Mohd-Yusof; Graham J Kaplan; Zuhair I Abdulla; Ryan J Lee; Cynthia A Crawford
Journal:  Eur J Pharmacol       Date:  2013-02-28       Impact factor: 4.432

10.  Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration.

Authors:  Yu Deng; Congcong Jiao; Chao Mi; Bin Xu; Yuehui Li; Fei Wang; Wei Liu; Zhaofa Xu
Journal:  Mol Neurobiol       Date:  2014-06-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.